Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...

The U.S. Food and Drug Administration says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

An online store has jumped on the Ozempic craze by releasing a “sexy” semaglutide injection costume just in time for ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...

Popular weight-loss drugs like Ozempic are used to treat obesity and diabetes. Now, researchers found that these drugs also ...

Doctors have issued a serious health warning over the extremely dangerous ‘faux-zempic’ as the weight loss drugs see an ...

Semaglutide, the same compound that’s in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) ...

The first patient has been dosed in a trial assessing the peptide-drug conjugate CBX-12 in patients with platinum-resistant or refractory ovarian cancer, according to a press release from Cybrexa ...

CAESAREA, Israel, Oct. 15, 2024 /PRNewswire/ -- Epitomee Medical Ltd. (TASE: EPIT) announces today that the company ...